+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Thoracic Surgery Market Report and Forecast 2023-2031

  • PDF Icon

    Report

  • 140 Pages
  • May 2023
  • Region: Global
  • Expert Market Research
  • ID: 5805827
The global thoracic surgery market size attained a value of USD 5 billion in 2022, driven by the increasing incidence of thoracic diseases, particularly lung. The market size is anticipated to grow at a CAGR of 9% during the forecast period of 2023-2031 to achieve a value of USD 10.8 billion by 2031.

Thoracic Surgery: Introduction

Thoracic surgery is a specialized field of surgery that focuses on the diagnosis and treatment of conditions affecting the organs within the chest cavity, including the lungs, heart, esophagus, and other thoracic structures. It involves surgical procedures such as lung resections, heart surgeries, esophageal surgeries, and thoracic tumor removal.

The primary goal of thoracic surgery is to restore or improve the function of thoracic organs, alleviate symptoms, and improve the overall quality of life for patients. Thoracic surgeons utilize advanced surgical techniques, equipment, and technologies to perform both open and minimally invasive procedures. Thoracic surgery is a highly specialized and multidisciplinary field that involves collaboration among thoracic surgeons, pulmonologists, oncologists, anesthesiologists, and other healthcare professionals. The field continues to evolve with ongoing research, technological advancements, and the development of new surgical techniques and treatment modalities. The focus is on improving patient outcomes, enhancing surgical precision, and optimizing patient care.

Key Trends in the Thoracic Surgery Market

Some key trends involved in the thoracic surgery market are as follows:
  • Minimally Invasive Techniques: One of the significant trends in thoracic surgery is the increasing adoption of minimally invasive techniques, such as video-assisted thoracic surgery (VATS) and robotic-assisted surgery. These techniques offer several advantages over traditional open surgeries, including smaller incisions, reduced blood loss, shorter hospital stays, faster recovery, and improved patient outcomes
  • Advanced Imaging and Navigation Technology: The integration of advanced imaging technologies, such as computed tomography (CT) scans and magnetic resonance imaging (MRI), with surgical navigation systems has revolutionized thoracic surgery. These technologies enable surgeons to obtain precise anatomical information, plan surgeries more accurately, and navigate complex structures with greater precision, enhancing surgical outcomes and patient safety
  • Personalized Medicine and Precision Surgery: With advancements in genetic testing and molecular profiling, there is a growing trend towards personalized medicine in thoracic surgery. Genetic markers and molecular profiles are used to identify specific tumor characteristics, allowing for tailored treatment approaches. Precision surgery techniques, such as targeted lung cancer resections based on tumor location and size, are also gaining prominence

Thoracic Surgery Market Segmentations

Market Breakup by Product

  • Surgical Sutures and Staples
  • Handheld Surgical equipment
  • Electrosurgical Devices

Market Breakup by End User

  • End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Market Breakup by Region

North America

  • United States of America
  • Canada

Europe

  • United Kingdom
  • Germany
  • France
  • Italy
  • Others

Asia Pacific

  • China
  • Japan
  • India
  • ASEAN
  • Australia
  • Others

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Others

Middle East and Africa

  • Saudi Arabia
  • United Arab Emirates
  • Nigeria
  • South Africa
  • Others

Thoracic Surgery Market Scenario

The global market for thoracic surgery is experiencing significant growth due to several factors, including the increasing prevalence of thoracic diseases, advancements in surgical techniques, and rising demand for minimally invasive procedures. Thoracic surgery is performed to treat various conditions, such as lung cancer, esophageal disorders, thoracic trauma, and congenital abnormalities. The market encompasses a wide range of surgical instruments, devices, and equipment used in thoracic procedures.

The market for thoracic surgery is driven by the growing incidence of thoracic diseases, particularly lung cancer. According to the World Health Organization (WHO), lung cancer is one of the leading causes of cancer-related deaths worldwide, creating a substantial demand for surgical interventions. Additionally, the rising prevalence of other thoracic conditions, such as esophageal disorders and thoracic trauma, further contributes to market growth.

Advancements in surgical techniques and technologies have revolutionized thoracic surgery. The adoption of minimally invasive procedures, such as VATS and robotic-assisted surgery, has gained significant popularity. These techniques offer benefits such as reduced postoperative pain, shorter hospital stays, faster recovery, and improved cosmetic outcomes. As a result, there is a growing demand for minimally invasive thoracic surgery devices and instruments.

The market for thoracic surgery is also influenced by the increasing focus on patient-centric care and personalized medicine. Surgeons are striving to provide tailored treatment approaches based on the individual characteristics of patients, including genetic profiles and tumor biomarkers. This has led to the development of targeted therapies and precision surgical techniques, driving the demand for specialized instruments and devices
Geographically, North America and Europe dominate the thoracic surgery market, primarily due to the presence of advanced healthcare infrastructure, well-established reimbursement systems, and high awareness among patients and healthcare professionals. However, the market in the Asia Pacific region is expected to witness significant growth in the coming years, driven by improving healthcare facilities, increasing healthcare expenditure, and a rising prevalence of thoracic diseases.

Thoracic Surgery Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
  • Biosensors International Group
  • BIOTRONIK SE & Co
  • BioVentrix, Inc
  • C. R. Bard, Inc
  • CardiacAssist, Inc
  • CircuLite Inc
  • Jhonson & Jhonson
  • Corindus Vascular Robotics
  • Medtronic
  • Heartware International Inc

Table of Contents

1 Preface2 Report Coverage - Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Opportunities and Challenges in the Market
8 Global Thoracic Surgery Market Analysis
8.1 Key Industry Highlights
8.2 Global Thoracic Surgery Historical Market (2018-2022)
8.3 Global Thoracic Surgery Market Forecast (2023-2028)
8.4 Global Thoracic Surgery Market by Product
8.4.1 Surgical Sutures and Staples
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2018-2022)
8.4.1.3 Forecast Trend (2023-2028)
8.4.2 Handheld Surgical Equipment
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2018-2022)
8.4.2.3 Forecast Trend (2023-2028)
8.4.2.3.1 Forceps and Spatulas
8.4.2.3.2 Retractors
8.4.2.3.3 Dilators
8.4.2.3.4 Graspers
8.4.2.3.5 Auxiliary Instruments
8.4.2.3.6 Cutter Instruments
8.4.2.3.7 Others
8.4.3 Electrosurgical Devices
8.4.3.1 Market Share
8.4.3.2 Historical Trend (2018-2022)
8.4.3.3 Forecast Trend (2023-2028)
8.5 Global Thoracic Surgery Market by Surgery Type
8.5.1 Lobectomy
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2018-2022)
8.5.1.3 Forecast Trend (2023-2028)
8.5.2 Wedge Resection
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2018-2022)
8.5.2.3 Forecast Trend (2023-2028)
8.5.3 Pneumonectomy
8.5.3.1 Market Share
8.5.3.2 Historical Trend (2018-2022)
8.5.3.3 Forecast Trend (2023-2028)
8.5.4 Pleurectomy
8.5.4.1 Market Share
8.5.4.2 Historical Trend (2018-2022)
8.5.4.3 Forecast Trend (2023-2028)
8.5.5 Others
8.6 Global Thoracic Surgery Market by Application
8.6.1 Oesophageal Cancer
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2018-2022)
8.6.1.3 Forecast Trend (2023-2028)
8.6.2 Gastroesophageal Reflux
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2018-2022)
8.6.2.3 Forecast Trend (2023-2028)
8.6.3 Others
8.7 Global Thoracic Surgery Market by Region
8.7.1 North America
8.7.1.1 Market Share
8.7.1.2 Historical Trend (2018-2022)
8.7.1.3 Forecast Trend (2023-2028)
8.7.2 Europe
8.7.2.1 Market Share
8.7.2.2 Historical Trend (2018-2022)
8.7.2.3 Forecast Trend (2023-2028)
8.7.3 Asia Pacific
8.7.3.1 Market Share
8.7.3.2 Historical Trend (2018-2022)
8.7.3.3 Forecast Trend (2023-2028)
8.7.4 Latin America
8.7.4.1 Market Share
8.7.4.2 Historical Trend (2018-2022)
8.7.4.3 Forecast Trend (2023-2028)
8.7.5 Middle East and Africa
8.7.5.1 Market Share
8.7.5.2 Historical Trend (2018-2022)
8.7.5.3 Forecast Trend (2023-2028)
9 North America Thoracic Surgery Market Analysis
9.1 United States of America
9.1.1 Market Share
9.1.2 Historical Trend (2018-2022)
9.1.3 Forecast Trend (2023-2028)
9.2 Canada
9.2.1 Market Share
9.2.2 Historical Trend (2018-2022)
9.2.3 Forecast Trend (2023-2028)
10 Europe Thoracic Surgery Market Analysis
10.1 United Kingdom
10.1.1 Market Share
10.1.2 Historical Trend (2018-2022)
10.1.3 Forecast Trend (2023-2028)
10.2 Germany
10.2.1 Market Share
10.2.2 Historical Trend (2018-2022)
10.2.3 Forecast Trend (2023-2028)
10.3 France
10.3.1 Market Share
10.3.2 Historical Trend (2018-2022)
10.3.3 Forecast Trend (2023-2028)
10.4 Italy
10.4.1 Market Share
10.4.2 Historical Trend (2018-2022)
10.4.3 Forecast Trend (2023-2028)
10.5 Others
11 Asia Pacific Thoracic Surgery Market Analysis
11.1 China
11.1.1 Market Share
11.1.2 Historical Trend (2018-2022)
11.1.3 Forecast Trend (2023-2028)
11.2 Japan
11.2.1 Market Share
11.2.2 Historical Trend (2018-2022)
11.2.3 Forecast Trend (2023-2028)
11.3 India
11.3.1 Market Share
11.3.2 Historical Trend (2018-2022)
11.3.3 Forecast Trend (2023-2028)
11.4 ASEAN
11.4.1 Market Share
11.4.2 Historical Trend (2018-2022)
11.4.3 Forecast Trend (2023-2028)
11.5 Australia
11.5.1 Market Share
11.5.2 Historical Trend (2018-2022)
11.5.3 Forecast Trend (2023-2028)
11.6 Others
12 Latin America Thoracic Surgery Market Analysis
12.1 Brazil
12.1.1 Market Share
12.1.2 Historical Trend (2018-2022)
12.1.3 Forecast Trend (2023-2028)
12.2 Argentina
12.2.1 Market Share
12.2.2 Historical Trend (2018-2022)
12.2.3 Forecast Trend (2023-2028)
12.3 Mexico
12.3.1 Market Share
12.3.2 Historical Trend (2018-2022)
12.3.3 Forecast Trend (2023-2028)
12.4 Others
13 Middle East and Africa Thoracic Surgery Market Analysis
13.1 Saudi Arabia
13.1.1 Market Share
13.1.2 Historical Trend (2018-2022)
13.1.3 Forecast Trend (2023-2028)
13.2 United Arab Emirates
13.2.1 Market Share
13.2.2 Historical Trend (2018-2022)
13.2.3 Forecast Trend (2023-2028)
13.3 Nigeria
13.3.1 Market Share
13.3.2 Historical Trend (2018-2022)
13.3.3 Forecast Trend (2023-2028)
13.4 South Africa
13.4.1 Market Share
13.4.2 Historical Trend (2018-2022)
13.4.3 Forecast Trend (2023-2028)
13.5 Others
14 Market Dynamics
14.1 SWOT Analysis
14.1.1 Strengths
14.1.2 Weaknesses
14.1.3 Opportunities
14.1.4 Threats
14.2 Porter’s Five Forces Analysis
14.2.1 Supplier’s Power
14.2.2 Buyer’s Power
14.2.3 Threat of New Entrants
14.2.4 Degree of Rivalry
14.2.5 Threat of Substitutes
14.3 Key Indicators for Demand
14.4 Key Indicators for Price
15 Value Chain Analysis
16 Competitive Landscape
16.1 Market Structure
16.2 Company Profiles
16.2.1 AbbVie Inc. (NYSE: ABBV)
16.2.1.1 Company Overview
16.2.1.2 Product Portfolio
16.2.1.3 Demographic Reach and Achievements
16.2.1.4 Certifications
16.2.2 Boston Scientific Corporation (NYSE: BSX)
16.2.2.1 Company Overview
16.2.2.2 Product Portfolio
16.2.2.3 Demographic Reach and Achievements
16.2.2.4 Certifications
16.2.3 Edwards Lifesciences Corporation (NYSE: EW)
16.2.3.1 Company Overview
16.2.3.2 Product Portfolio
16.2.3.3 Demographic Reach and Achievements
16.2.3.4 Certifications
16.2.4 LivaNova PLC (NASDAQ: LIVN)
16.2.4.1 Company Overview
16.2.4.2 Product Portfolio
16.2.4.3 Demographic Reach and Achievements
16.2.4.4 Certifications
16.2.5 Medtronic PLC (NYSE: MDT)
16.2.5.1 Company Overview
16.2.5.2 Product Portfolio
16.2.5.3 Demographic Reach and Achievements
16.2.5.4 Certifications
16.2.6 Others
17 Key Trends and Developments in the Market

Companies Mentioned

  • AbbVie Inc. (NYSE: ABBV)
  • Boston Scientific Corp. (NYSE: BSX)
  • Edwards Lifesciences Corp. (NYSE: EW)
  • LivaNova Plc (NASDAQ: LIVN)
  • Medtronic Plc (NYSE: MDT)

Methodology

Loading
LOADING...

Table Information